BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 10498624)

  • 1. Molecular characterization of autosomal recessive chronic granulomatous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox.
    Patiño PJ; Rae J; Noack D; Erickson R; Ding J; de Olarte DG; Curnutte JT
    Blood; 1999 Oct; 94(7):2505-14. PubMed ID: 10498624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal recessive chronic granulomatous disease caused by novel mutations in NCF-2, the gene encoding the p67-phox component of phagocyte NADPH oxidase.
    Noack D; Rae J; Cross AR; Muñoz J; Salmen S; Mendoza JA; Rossi N; Curnutte JT; Heyworth PG
    Hum Genet; 1999 Nov; 105(5):460-7. PubMed ID: 10598813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly.
    Leusen JH; Meischl C; Eppink MH; Hilarius PM; de Boer M; Weening RS; Ahlin A; Sanders L; Goldblatt D; Skopczynska H; Bernatowska E; Palmblad J; Verhoeven AJ; van Berkel WJ; Roos D
    Blood; 2000 Jan; 95(2):666-73. PubMed ID: 10627478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombination events between the p47-phox gene and its highly homologous pseudogenes are the main cause of autosomal recessive chronic granulomatous disease.
    Roesler J; Curnutte JT; Rae J; Barrett D; Patino P; Chanock SJ; Goerlach A
    Blood; 2000 Mar; 95(6):2150-6. PubMed ID: 10706888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three novel mutations in CYBA among 22 Iranians with Chronic granulomatous disease.
    Badalzadeh M; Tajik S; Fazlollahi MR; Houshmand M; Fattahi F; Alizadeh Z; Movahedi M; Adab Z; Khotaei GT; Hamidieh AA; Heidarnazhad H; Pourpak Z
    Int J Immunogenet; 2017 Dec; 44(6):314-321. PubMed ID: 28941186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of 9 new families with chronic granulomatous disease caused by mutations in CYBA, the gene encoding p22(phox).
    Rae J; Noack D; Heyworth PG; Ellis BA; Curnutte JT; Cross AR
    Blood; 2000 Aug; 96(3):1106-12. PubMed ID: 10910929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency.
    Ishibashi F; Nunoi H; Endo F; Matsuda I; Kanegasaki S
    Hum Genet; 2000 May; 106(5):473-81. PubMed ID: 10914676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of autosomal recessive chronic granulomatous disease in iran.
    Teimourian S; de Boer M; Roos D
    J Clin Immunol; 2010 Jul; 30(4):587-92. PubMed ID: 20407811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disturbed interaction of p21-rac with mutated p67-phox causes chronic granulomatous disease.
    Leusen JH; de Klein A; Hilarius PM; Ahlin A; Palmblad J; Smith CI; Diekmann D; Hall A; Verhoeven AJ; Roos D
    J Exp Med; 1996 Oct; 184(4):1243-9. PubMed ID: 8879195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of four cases of chronic granulomatous disease caused by defects in NCF-2: the gene encoding the p67-phox.
    Badalzadeh M; Fattahi F; Fazlollahi MR; Tajik S; Bemanian MH; Behmanesh F; Movahedi M; Houshmand M; Pourpak Z
    Iran J Allergy Asthma Immunol; 2012 Dec; 11(4):340-4. PubMed ID: 23264412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity.
    Matute JD; Arias AA; Wright NA; Wrobel I; Waterhouse CC; Li XJ; Marchal CC; Stull ND; Lewis DB; Steele M; Kellner JD; Yu W; Meroueh SO; Nauseef WM; Dinauer MC
    Blood; 2009 Oct; 114(15):3309-15. PubMed ID: 19692703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementation of NADPH oxidase in p67-phox-deficient CGD patients p67-phox/p40-phox interaction.
    Vergnaud S; Paclet MH; El Benna J; Pocidalo MA; Morel F
    Eur J Biochem; 2000 Feb; 267(4):1059-67. PubMed ID: 10672014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel and unusual case of chronic granulomatous disease in a child with a homozygous 36-bp deletion in the CYBA gene (A22(0)) leading to the activation of a cryptic splice site in intron 4.
    Stasia MJ; Bordigoni P; Martel C; Morel F
    Hum Genet; 2002 May; 110(5):444-50. PubMed ID: 12073015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-exon skipping due to a point mutation in p67-phox--deficient chronic granulomatous disease.
    Aoshima M; Nunoi H; Shimazu M; Shimizu S; Tatsuzawa O; Kenney RT; Kanegasaki S
    Blood; 1996 Sep; 88(5):1841-5. PubMed ID: 8781442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.
    Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA
    J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual NADPH oxidase and survival in chronic granulomatous disease.
    Kuhns DB; Alvord WG; Heller T; Feld JJ; Pike KM; Marciano BE; Uzel G; DeRavin SS; Priel DA; Soule BP; Zarember KA; Malech HL; Holland SM; Gallin JI
    N Engl J Med; 2010 Dec; 363(27):2600-10. PubMed ID: 21190454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular significance of flow cytometric analysis for reactive oxygen species production and residual p67
    Miyazawa H; Muraoka M; Matsuda Y; Toma T; Morio T; Shigemura T; Haraguchi K; Matsubayashi T; Kawai T; Shirai Y; Wada T
    Scand J Immunol; 2024 Jul; 100(1):e13372. PubMed ID: 38654426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of patients with p47-phox-deficient chronic granulomatous disease: The significance of recombination events between the p47-phox gene (NCF1) and its highly homologous pseudogenes.
    Vázquez N; Lehrnbecher T; Chen R; Christensen BL; Gallin JI; Malech H; Holland S; Zhu S; Chanock SJ
    Exp Hematol; 2001 Feb; 29(2):234-43. PubMed ID: 11166463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update).
    Roos D; Kuhns DB; Maddalena A; Bustamante J; Kannengiesser C; de Boer M; van Leeuwen K; Köker MY; Wolach B; Roesler J; Malech HL; Holland SM; Gallin JI; Stasia MJ
    Blood Cells Mol Dis; 2010 Apr; 44(4):291-9. PubMed ID: 20167518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
    Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
    J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.